Direct medical costs of complications resulting from type 2 diabetes in the U.S.

Diabetes Care

Volumn 21, Issue 7, 1998, Pages 1122-1128

  O'Brien, Judith A ^a   Shomphe, Lori A ^a   Kavanagh, Patricia L ^a   Raggio, Gabriel ^a   Jaime Caro, J ^a,b  

^a CARO RESEARCH INSTITUTE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; COST CONTROL; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; STROKE;

ANIMALS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COSTS AND COST ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DIRECT SERVICE COSTS; HUMANS; HYPOGLYCEMIA; RABBITS; UNITED STATES;

EID: 0031821715     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.7.1122     Document Type: Article

References (49)

1. Cowie CC, Eberhardt MS (Eds.): Diabetes 1996: Vital Statistics. Alexandria, VA, American Diabetes Association, 1996
2. American Diabetes Association: Diabetes Pacts and Figures. Alexandria, VA, American Diabetes Association, 1997
3. Most RS, Sinnock P: The epidemiology of lower extremity amputations in diabetic individuals, Diabetes Cart 6:87-91, 1983
4. Centers for Disease Control: Diabetes Surveillance, 1993. Atlanta, GA, U.S. Department of Health and Human Services, Public Health Service, 1993
5. Levin ME, O'Neal LW: The Diabetic Foot: Pathophysiology, Evaluation, and Treatment. 4th ed. St. Louis, MO, CV Mosby, 1988
6. U.S. Renal Data System: USRDS 1996 Annual Data Report. Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1996
7. Apelqvist J, Ragnarson-Tennvall G, Larsson J, Persson U: Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int 16:388-394, 1995
8. Narins B, Karins G: Clinical features and health-care costs of diabetic nephropathy. Diabetes Care 11:833-839, 1988
9. Jacobs J, Sena M, Fox N: The cost of hospitalization for the late complications of diabetes in the United States. Diabet Med 8 (Symposium):S23-S29, 1991
10. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA: The economic costs of non-insulin-dependent diabetes mellitus. JAMA 262:2708-2713, 1989
11. Glauber H, Brown J: Impact of cardiovascular disease on health care utilization in a defined diabetic population. J Clin Epidemiol 47:1133-1142, 1994
12. Rubin RJ, Altman WM, Mendelson DN: Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 78:809A-809F, 1994
13. Eastman RC, Javitt JC, Herman WH, Dasgach EJ, Copley-Merriman C, Maier W, Dong F, Manninen D, Zbrozek AS, Kotsanos J, Garfield SA, Harris M: Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 20:735-744, 1997
14. Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Zbrozek AS, Dong F, Manninen D, Garfield SA, Copley-Merriman C, Maier W, Eastman JF, Kotsanos J, Cowie CC, Harris M: Model of complications of NIDDM, I. Model construction and assumptions. Diabetes Care 20:725-734, 1997
15. St. Anthony's ICD-9-CM Code Book Reston, VA, St. Anthony Publishing, 1996
16. American Medical Association: Physicians' Current Procedural Terminology. Chicago, American Medical Association, 1996
17. Monitoring the Impact of Medicare Physician Payment Reform on Utilization and Access. 1995 Report to Congress. Baltimore, MD, Health Care Financing Administration, 1995
18. Health Care Financing Review: Medicare and Medicaid Statistical Supplement, 1996. Baltimore, MD, U.S. Dept. of Health and Human Services, HCFA, Office of Research and Demonstrations, October 1996 (HCFA publ. no. 03386)
19. Manton KG, Cornelius ES, Woodbury MA: Nursing residents: a multivariate analysis of their medical, behavioral, psychosocial, and service use characteristics. J Gerontol 50A:242-251, 1995
20. 1995 The Guide to the Nursing Home Industry. Baltimore, MD, HCIA and Arthur Andersen, 1995
21. Nursing Facilities in Massachusetts: 1994 Update. Boston, MA, Rate Setting Commission, February 1996
22. 1996 Drug Topics Red Book. Montvale, NJ, Medical Economics, 1996
23. Annual Report to Congress, 1996. Washington, DC, Physician Payment Review Commission, 1996
24. Unstable Angina: Diagnosis and Management. Clinical Practice Guideline Number 10. Rockville, MD, U.S. Dept. of Health and Human Services, Agency for Health Care Policy and Research, May 1994 (amended) (AHCPR publ. no. 94-0602)
25. Mark DB, Hlatky MA, Califf RM, Naylor CD, Leek L, Armstrong PW Barbash G, White H, Simoons ML, Nelson CL, Clapp- Channing N, Knight JD, Harrell FE Jr, Simes J, Topol EJ: Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl Med:332:1418-1424, 1995
26. Deedwania P, Amsterdam E, Vagelos R: Evidence-based, cost-effective risk stratification and management after myocardial infarction. Arch Intern Med 157:273-280, 1997
27. Mark DB, Lam LC, Lee KL, Jones RH, Pryor DB, Stack RS, Williams RB, Clapp-Channing NE, Califf RM, Hlatky MA: Effects of coronary angioplasty, coronary bypass surgery, and medical therapy on employment in patients with coronary artery disease: a prospective comparison study. Ann Intern Med 120:111-117, 1994
28. Caro JJ, O'Brien JA, Klittich W, Jackson JD: The economic impact of Warfarin prophylaxis in nonvalvular atrial fibrillation. Dis Management Clin Outcomes 1:54-60, 1997
29. Ritz E, Stefanski A: Diabetic nephropathy in type II diabetes. Am J Kidney Dis 27:167- 194, 1996
30. American Diabetes Association: Diagnosis and management of nephropathy in patients with diabetes mellitus (Consensus Statement). Diabetes Care 19 (Suppl. 1):S103- S106, 1996
31. Jacobson HR, Sriker GE: Report on a workshop to develop management recom mandations for the prevention of chronic renal disease. Am J Kidney Dis 25:103-106, 1995
32. The Diabetes Control and Complications Trial Research Group: Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA 276:1409-1415, 1996
33. American Diabetes Association: Medical Management of Non-Insulin-Dependent (Type II) Diabetes. 3rd ed. Alexandria, VA, American Diabetes Association, 1994
34. American Academy of Ophthalmology: Preferred Practice Patterns. San Francisco, CA, American Academy of Ophthalmology, 1993
35. Chiang Y, Bassi LJ, Javitt JC: Federal budgetary cost of blindness. Milbank Q 70:319-340, 1992
36. American Diabetes Association: Diabetic neuropathy (Position Statement). Diabetes Care 19 (Suppl. 1):S67-S71, 1996
37. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 19 (Suppl. 1):S8-S15, 1996
38. Humphrey LL, Palumbo PJ, Butters MA, Hallett JW Jr, Chu CR O'Fallon WM, Ballard DJ: The contribution of non-insulin- dependent diabetes to lower-extremity amputation in the community. Arch Intern Med 154:885-892, 1994
39. Reiber G: Epidemiology of the diabetic foot. In The Diabetic Foot. 5th ed. Levin M, O'Neal L, Bowker J, Eds. Boston, MA, Mosby Year Book, 1993
40. Eneroth M, Persson BM: Amputation for occlusive arterial disease: a prospective multicentre study of 177 amputees. Int Orthop 16:383-387, 1992
41. Polhjolainen T, Alaranta H, Wikstrom J: Primary survival and prosthetic fitting of lower limb amputees. Prosthet Orthot Int 13:63-69, 1989
42. Williams M: Long-term cost comparison of major limb salvage using the Ilizarov Method versus amputation. Clin Orthop 301:156-158, 1994
43. Moore TJ, Barren J, Hutchinson F III, Golden C, Ellis C, Humphries D: Prosthetic usage following major lower extremity amputation. Clin Orthop 238:219-224, 1989
44. Steinberg FU, Sunwoo I, Roettger RF: Prosthetic rehabilitation of geriatric amputee patients: a follow-up study Arch Phys Med Rehab 66:742-745, 1985
45. Volpicelli LJ, Chambers LB, Wagner FW: Amputation levels of bilateral lower- extremity amputees. J Bone Joint Surg Am 65A:599-604, 1983
46. Reiber GE: Who is at risk of limb loss and what to do about it? J Rehab Res Dev 31:357-362, 1994
47. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Johnson Nagel N, Comstock JP, Emanuele NW, Levin SR, Henderson W, Sook Lee HS, VA CSDM Group: Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes. Diabetes Care 18:1113-1123, 1995
48. Diabetes Control and Complications Trial Research Group: Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18:1415-1427, 1995
49. Center for Economic Studies in Medicine: Direct and Indirect Costs of Diabetes in the United States in 1992. Alexandria, VA, American Diabetes Association, 1993